天瑞儀器(300165.SZ):收到崑山消防救援大隊罰款1.5萬元
格隆匯11月4日丨天瑞儀器(300165.SZ)公佈,公司於2021年11月3日收到崑山市消防救援大隊2021年10月18日出具的《行政處罰決定書》。
主要內容如下:
現查明2021年7月19日,崑山消防救援大隊消防監督員在檢查中發現江蘇天瑞儀器股份有限公司存在以下問題:1、模塊故障導致宿舍樓報警設施聯動測試主電未切,應急照明燈未啟用,電梯未迫降;2、研發樓排煙設施無法正常啟動,該消防設施未保持完好有效的行為違反了《中華人民共和國消防法》第十六條第一款第二項的規定。根據《中華人民共和國消防法》第六十條第一款第一項之規定,現決定給予江蘇天瑞儀器股份有限公司罰款人民幣1.5萬元的處罰。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.